| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815395 | Neuropharmacology | 2013 | 8 Pages |
Abstract
⺠AHN 2-005 is a selective dopamine reuptake inhibitor lacking reinforcing effects. ⺠AHN 2-005 improved prefrontal-dependent cognition. ⺠AHN 2-005 increased extracellular dopamine and norepinephrine in prefrontal cortex. ⺠These actions are similar to those produced by ADHD-related drugs.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Brooke E. Schmeichel, Frank P. Zemlan, Craig W. Berridge,